Want to see SE:ASKER full AI Analyst Report?
ASKER Stock Chart & Stats
kr82.25
--
Market closed
kr82.25
--
Day’s Range― - ―
52-Week Rangekr56.20 - kr95.56
Previous CloseN/A
VolumeN/A
Average Volume (3M)704.38K
Market Cap
kr27.45B
Enterprise Valuekr35.90B
Total Cash (Recent Filing)kr777.00M
Total Debt (Recent Filing)kr6.48B
Price to Earnings (P/E)40.2
Beta0.69
Next Earnings
Nov 04, 2026EPS Estimate
0.6Next Dividend Ex-DateN/A
Dividend Yield0.55%
Share Statistics
EPS (TTM)1.78
Shares Outstanding383,706,480
10 Day Avg. Volume508,866
30 Day Avg. Volume704,377
Financial Highlights & Ratios
PEG Ratio2.05
Price to Book (P/B)4.74
Price to Sales (P/S)1.85
P/FCF Ratio42.11
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)2.82
Revenue Forecast (FY)kr19.30B
Bulls Say, Bears Say
Bulls Say
Revenue And Profitability ImprovementTTM revenue growth alongside a substantial improvement in net margin indicates stronger earnings conversion as the company expands. This combination provides a better foundation for reinvestment, resilience, and sustained profit development over the next several quarters.
Healthy Distributor MarginsThe reported gross and EBIT margins demonstrate that Asker generates meaningful value beyond distribution volume alone. Maintaining this profitability profile can support operating stability, fund commercial investment, and strengthen the company’s ability to compete across healthcare supply markets.
Improved Capital StructureThe substantial reduction in leverage and growth in equity indicate a materially stronger capital structure than in prior years. Greater balance-sheet capacity should improve financial flexibility, reduce dependence on debt financing, and help support continued expansion or investment.
Bears Say
Weakening Free Cash Flow MomentumAlthough free cash flow remains positive, its recent decline signals weaker cash-generation momentum than the company’s earnings trend. If this persists, it could limit internally funded growth, reduce flexibility for investment, and make working-capital demands more consequential.
Modest Margins And Earnings VolatilityThe combination of modest overall margins and uneven net income suggests that profitability still has limited protection against adverse pricing or cost movements. This volatility can make earnings less predictable and leaves less operating buffer during periods of weaker execution.
Substantial Debt And Moderate ReturnsDespite improved leverage, the absolute debt balance remains material and returns on equity are only moderate. The company therefore still needs sustained execution to convert its larger asset base into stronger shareholder returns while managing ongoing financing obligations.
Asker Healthcare Group AB News
ASKER FAQ
What was Asker Healthcare Group AB’s price range in the past 12 months?
Asker Healthcare Group AB lowest stock price was kr56.20 and its highest was kr95.56 in the past 12 months.
What is Asker Healthcare Group AB’s market cap?
Asker Healthcare Group AB’s market cap is kr27.45B.
When is Asker Healthcare Group AB’s upcoming earnings report date?
Asker Healthcare Group AB’s upcoming earnings report date is Nov 04, 2026 which is in 6 days.
How were Asker Healthcare Group AB’s earnings last quarter?
Asker Healthcare Group AB released its earnings results on Jul 21, 2026. The company reported kr0.57 earnings per share for the quarter, missing the consensus estimate of kr0.66 by -kr0.09.
Is Asker Healthcare Group AB overvalued?
According to Wall Street analysts Asker Healthcare Group AB’s price is currently Overvalued.
Does Asker Healthcare Group AB pay dividends?
Asker Healthcare Group AB pays a Notavailable dividend of kr0.39 which represents an annual dividend yield of 0.55%. See more information on Asker Healthcare Group AB dividends here
What is Asker Healthcare Group AB’s EPS estimate?
Asker Healthcare Group AB’s EPS estimate is 0.6.
How many shares outstanding does Asker Healthcare Group AB have?
Asker Healthcare Group AB has 383,706,480 shares outstanding.
What happened to Asker Healthcare Group AB’s price movement after its last earnings report?
Asker Healthcare Group AB reported an EPS of kr0.57 in its last earnings report, missing expectations of kr0.66. Following the earnings report the stock price went down -7.706%.
Which hedge fund is a major shareholder of Asker Healthcare Group AB?
Currently, no hedge funds are holding shares in SE:ASKER
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Asker Healthcare Group AB
Asker Healthcare Group AB is a comprehensive provider of medical supplies, equipment, and related solutions, all designed to enhance patient care. Their broad product portfolio encompasses essential consumables such as protective items, infusion supplies, and wound dressings, alongside advanced medical apparatus like endoscopy systems, incubators, and ventilators. They also distribute pharmaceuticals and offer diagnostic instruments for conditions including diabetes and hypertension. The company equips operating rooms, polyclinics, and day surgery facilities with specialized medical devices, and provides veterinary equipment, hygiene solutions, and targeted products for urology, ultrasound diagnostics, laser treatment, and regenerative medicine. Additionally, their offerings include defibrillators, advanced wound care products, and critical protection and trauma supplies for emergency services, law enforcement, and military personnel, as well as products for beauty clinics. Beyond their core product range, Asker Healthcare Group develops and markets proprietary disposable medical items under the Evercare, Selefa, and Embra brands, and serves as a key distributor of ophthalmic surgical products. They also create and sell innovative solutions for time management, communication, and cognitive support, aimed at schools, assistive technology centers, and various public services. The group extends its offerings to a variety of patient support services, including specialized assistance for wound, diabetes, and urological care, in addition to ostomy, urology, and rehabilitation programs. They supply products for physiotherapy practices, provide exercise and treatment equipment, and offer both sales and rentals of mobility aids and rehabilitation devices, including pressure-relieving mattresses and cushions, which they also manufacture and distribute. Ambulance services are another facet of their diverse operations. Founded in 2018 and headquartered in Danderyd, Sweden, Asker Healthcare Group AB maintains an extensive operational presence across numerous European countries, specifically Sweden, Norway, Finland, Estonia, Latvia, Lithuania, the Netherlands, Belgium, Luxembourg, Denmark, the United Kingdom, Ireland, Germany, Austria, Switzerland, the Czech Republic, and Poland.







